Written by Charles Gumbley, BHSc (Clinical Nutrition), DipHSc (Western Herbal Medicine)
Evidence checked: 19 July 2026
This article is general education, not personalised medical advice. Do not replace prescribed treatment with pine bark extract. Ask a doctor or pharmacist before use with medicines, before surgery, during pregnancy or breastfeeding, or for a child.
Conflict disclosure: Nutrition Market sells supplements. This guide does not rank, link or display Pycnogenol products, categories, prices or stock feeds.
Claims about the extract are often presented as a long list: better circulation, blood pressure, skin, joints, attention, glucose control and sexual function. Human research exists, but the strongest independent review found that study size, reporting and certainty were too limited for definitive conclusions. “Studied” is not the same as “proven to work”.
Key points
- Pycnogenol is a trademarked French maritime pine bark extract, not the name of every pine bark supplement.
- A 2020 Cochrane review of 27 randomised trials rated the condition-specific evidence very low certainty.
- Mechanisms and antioxidant activity do not establish a treatment benefit.
- Product labels, medicine interactions and the exact extract studied matter.
French maritime pine bark extract: what Pycnogenol is
Pycnogenol is a standardised extract of French maritime pine bark from Pinus pinaster. It contains procyanidins and related polyphenols. Pycnogenol® French maritime pine bark is a defined branded material; generic pine bark extracts may use different species, extraction methods and concentrations.
That distinction matters. This plant extract is not interchangeable with every extract from pine. A clinical trial of one standardised material cannot validate another supplement merely because both mention pine bark. It also cannot validate a multi-ingredient formula in which the amount or identity is unclear.
Polyphenols can show antioxidant properties and antioxidant effects in laboratory systems. Researchers also study free radical activity, inflammatory signalling, endothelial function and each metabolite of maritime pine bark. These proposed mechanisms of Pycnogenol can help form a hypothesis, but a cell marker does not tell us whether a person feels better, avoids disease or safely reduces medicine.
Benefits of Pycnogenol: what the strongest review found
The most useful overview is the independent 2020 Cochrane systematic review. It included 27 randomised controlled trials and 1,641 participants across ten chronic disorders, including cardiovascular risk, diabetes, chronic venous insufficiency, osteoarthritis, attention deficit hyperactivity disorder and sexual dysfunction.¹
For most outcomes, only one small study was available. Outcomes and methods differed, reporting was often poor and certainty was rated very low. The authors could not reach definitive conclusions about the efficacy of Pycnogenol or its safety. The search was current to September 2019, so it does not answer every later question, but it is more reliable than selecting a favourable trial from a marketing page.
This does not prove the extract never has an effect. It means the size, reliability and clinical importance of any potential benefits remain uncertain for each health condition advertised to consumers. Pycnogenol may eventually show a reproducible use, but that has to be demonstrated outcome by outcome.
Effect of Pycnogenol on heart health and blood pressure
Blood-pressure research illustrates why review methods matter. A 2020 review and pooled analysis restricted its analysis to seven randomised, double-blind, placebo-controlled clinical studies involving 626 participants. It found no significant improvement in systolic pressure, diastolic pressure, mean arterial pressure or pulse pressure.²
Other meta-analyses have reported small changes in cardiometabolic markers, but results vary with study selection and quality. The effect of Pycnogenol supplementation on a biomarker is not evidence that it prevents a heart attack, stroke or other cardiovascular event. People taking antihypertensive, glucose-lowering, anticoagulant or antiplatelet medicines should not adjust treatment because of a supplement claim.
The trials were too inconsistent to determine the role of Pycnogenol in modifying blood pressure for routine care.
Heart health requires assessment of established risks such as blood pressure, lipids, smoking, diabetes and family history. Pine bark extract is not a substitute for that assessment or prescribed care.
Clinical studies of chronic venous insufficiency
A 2025 systematic review of emerging treatments for chronic venous insufficiency reported signals for reduced pain and improved resting microvascular flow with Pycnogenol.³ However, oedema and quality-of-life findings were less consistent, statistical heterogeneity was very high and the authors highlighted small samples and methodological differences.
That makes chronic venous insufficiency a research signal, not a self-treatment instruction. New one-sided swelling, warmth, redness, chest pain or shortness of breath requires urgent assessment because a clot cannot be diagnosed or managed with a supplement.
Pycnogenol supplements for ADHD, skin health and other claims
The Cochrane review could not establish reliable benefits for ADHD, osteoarthritis, diabetes or sexual dysfunction. The US National Center for Complementary and Integrative Health likewise states that evidence is insufficient to conclude that Pycnogenol is effective or safe for ADHD.⁴ Children should not take Pycnogenol in place of a properly assessed treatment plan.
Small clinical studies have examined skin elasticity, hydration and other effects on human skin. These effects on skin are formulation-, population- and outcome-specific. They do not establish that oral Pycnogenol or topical Pycnogenol treats a skin disease, reverses ageing or replaces sun protection.
A 2024 narrative review catalogued placebo-controlled trials to evaluate the potential of Pycnogenol across many systems.⁵ Its first author was employed by Horphag Research, the trademark owner. That disclosed conflict does not automatically invalidate the paper, but it means the review should not be treated as an independent efficacy verdict.
Antioxidant and anti-inflammatory effects are not clinical outcomes
Terms such as antioxidant activity and anti-inflammatory activity sound clinical, yet they often describe laboratory mechanisms or changes in surrogate markers. Reports about the effects of the antioxidant Pycnogenol may say that Pycnogenol inhibits or Pycnogenol induces a pathway under test. Those antioxidant activities, or an effect of polyphenolic extract in a model, do not establish a patient outcome. The body also uses controlled oxidative and inflammatory processes. Measuring a marker after Pycnogenol supplementation does not show that the person avoided disease or achieved a meaningful symptom improvement.
The relevant questions are whether the trial was randomised and blinded, whether the exact product was studied, whether the outcome mattered to patients, how large and durable the effect was, and whether another independent group reproduced it. Claims about a protective effect of Pycnogenol should not outrun those checks.
Clinical studies: how to examine the effect of Pycnogenol
For a clinical assessment of a supplement, first identify whether a trial used Pycnogenol alone or a combination of Pycnogenol with other ingredients. An examination of the effects should separate a participant-reported symptom from a laboratory marker and report the difference against placebo, not only change from baseline.
The effect of pine bark extract also depends on population, formulation and comparator. A statement such as Pycnogenol improves microcirculation or Pycnogenol may reduce oxidative stress is a testable claim, not a conclusion about disease prevention. Evidence that Pycnogenol changed one measure does not show that Pycnogenol helped the patient or that a different product will work.
The same caution applies to children taking Pycnogenol: one small ADHD trial cannot settle benefit, safety or the comparison with established care. This is why condition-specific systematic evidence matters more than the length of a list of studies.
Take Pycnogenol safely and read the Australian label
Short clinical studies generally report limited adverse effects, but the Cochrane review could not establish definitive safety. Long-term use, pregnancy, breastfeeding and use in children are not adequately resolved for broad self-treatment. The doses of Pycnogenol and trial durations vary; an amount expressed as mg daily in one study is not a public recommendation. Stop and seek advice for an allergic reaction or unexpected symptoms.
Memorial Sloan Kettering notes a potential interaction with anticoagulant or antiplatelet drugs because pine bark extract may affect platelet aggregation.⁶ A pharmacist should review it alongside warfarin, apixaban, rivaroxaban, clopidogrel, aspirin and other medicines rather than assuming a natural product is interaction-free. Pycnogenol and L-arginine have also been studied together, but combination research is not proof that casual co-use is suitable. Tell the surgical team about all supplements before a procedure.
In Australia, check the AUST number on the label. The TGA explains that AUST L medicines have not undergone pre-market efficacy assessment, while AUST L(A) and AUST R medicines have.⁷ Although Pycnogenol is used in listed supplements, an AUST L number supports legal supply within that framework; it does not prove every online health claim. Before taking pine bark extract or a supplement with Pycnogenol, compare the active ingredient, standardisation, warnings and AUST status with the exact material used in the cited research.
Questions about pine bark extract
Is it safe to take Pycnogenol every day?
Taking Pycnogenol daily cannot be declared universally safe. It depends on the exact product, duration, medicines, health conditions, pregnancy status and age. Long-term safety evidence is limited.
What are the benefits of taking Pycnogenol?
Trials have examined circulation, metabolic markers, joints, skin, attention and sexual function. The independent Cochrane review found the evidence too uncertain for definitive health outcomes across those conditions.
What not to take with Pycnogenol?
Do not combine it with anticoagulant or antiplatelet medicines without a doctor or pharmacist reviewing bleeding risk. Other medicines and supplements also need an individual interaction check.
How long does it take for Pycnogenol to work?
There is no evidence-based universal timeframe. Study duration varies by condition and outcome, and an effect in one trial cannot be transferred to another use or product.
References
- Robertson NU, et al. Pine bark (Pinus spp.) extract for treating chronic disorders. Cochrane Database of Systematic Reviews. 2020. doi:10.1002/14651858.CD008294.pub5. PubMed
- Fogacci F, et al. Effect of Pycnogenol on blood pressure: systematic review and meta-analysis. Angiology. 2020;71(3):217–225. doi:10.1177/0003319719889428. PubMed
- Miguel CB, et al. Emerging pharmacological interventions for chronic venous insufficiency. Pharmaceutics. 2025;17(1):59. doi:10.3390/pharmaceutics17010059. PubMed
- National Center for Complementary and Integrative Health. ADHD and complementary health approaches. NCCIH
- Weichmann F, Rohdewald P. Pycnogenol French maritime pine bark extract in randomised, double-blind, placebo-controlled human clinical studies. Frontiers in Nutrition. 2024;11:1389374. doi:10.3389/fnut.2024.1389374. PubMed
- Memorial Sloan Kettering Cancer Center. Pine bark extract. MSKCC
- Therapeutic Goods Administration. AUST numbers on medicine labels. TGA
